Kłusek, M., Chawrylak, K., Kuszneruk, J., Kubas, M. and Krzemińska, K. 2024. Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review. Quality in Sport. 18, (Jul. 2024), 53252. DOI:https://doi.org/10.12775/QS.2024.18.53252.